YOUR BUSINESS AUTHORITY
Springfield, MO
The co-founder and former CEO of 23andMe has inked a deal to buy the company.
Anne Wojcicki's TTAM Research Institute nonprofit bid $305 million for 23andMe’s assets via bankruptcy proceedings. Regeneron Pharmaceuticals had bid $256 million.
“I am thrilled that TTAM Research Institute will be able to continue the mission of 23andMe to help people access, understand and benefit from the human genome,” said Wojcicki, who stepped down as 23andMe's CEO when the company filed for bankruptcy in March.
Read more from CNBC.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach